{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:35:42Z","timestamp":1740123342954,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T00:00:00Z","timestamp":1580860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society For The Promotion Of Science","doi-asserted-by":"crossref","award":["18K18413"],"award-info":[{"award-number":["18K18413"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10792-020-01299-3","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T06:02:42Z","timestamp":1580882562000},"page":"1335-1345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Early changes of vascular lesions and responses to combined photodynamic therapy in patients with polypoidal choroidal vasculopathy"],"prefix":"10.1007","volume":"40","author":[{"given":"Kimiko","family":"Asano-Shimizu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoko","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asako","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Asaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1762-0797","authenticated-orcid":false,"given":"Ryo","family":"Obata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,5]]},"reference":[{"issue":"Suppl 1","key":"1299_CR1","first-page":"1","volume":"32","author":"LA Yannuzzi","year":"2012","unstructured":"Yannuzzi LA, Sorenson J, Spaide RF, Lipson B (2012) Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 32(Suppl 1):1\u20138","journal-title":"Retina"},{"issue":"5","key":"1299_CR2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","volume":"125","author":"CMG Cheung","year":"2018","unstructured":"Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, Gomi F, Koh AH, Lee WK, Wong TY (2018) Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology 125(5):708\u2013724. https:\/\/doi.org\/10.1016\/j.ophtha.2017.11.019","journal-title":"Ophthalmology"},{"key":"1299_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","volume":"53","author":"CW Wong","year":"2016","unstructured":"Wong CW, Yanagi Y, Lee WK, Ogura Y, Yeo I, Wong TY, Cheung CMG (2016) Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res 53:107\u2013139. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.04.002","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"1299_CR4","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/archopht.121.10.1392","volume":"121","author":"K Sho","year":"2003","unstructured":"Sho K, Takahashi K, Yamada H, Wada M, Nagai Y, Otsuji T, Nishikawa M, Mitsuma Y, Yamazaki Y, Matsumura M, Uyama M (2003) Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 121(10):1392\u20131396. https:\/\/doi.org\/10.1001\/archopht.121.10.1392","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"1299_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","volume":"144","author":"I Maruko","year":"2007","unstructured":"Maruko I, Iida T, Saito M, Nagayama D, Saito K (2007) Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 144(1):15\u201322. https:\/\/doi.org\/10.1016\/j.ajo.2007.03.047","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"1299_CR6","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00417-007-0575-8","volume":"245","author":"Y Liu","year":"2007","unstructured":"Liu Y, Wen F, Huang S, Luo G, Yan H, Sun Z, Wu D (2007) Subtype lesions of neovascular age-related macular degeneration in Chinese patients. Graefes Arch Clin Exp Ophthalmol 245(10):1441\u20131445. https:\/\/doi.org\/10.1007\/s00417-007-0575-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"1299_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10384-007-0498-2","volume":"52","author":"SH Byeon","year":"2008","unstructured":"Byeon SH, Lee SC, Oh HS, Kim SS, Koh HJ, Kwon OW (2008) Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients. Jpn J Ophthalmol 52(1):57\u201362. https:\/\/doi.org\/10.1007\/s10384-007-0498-2","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"1299_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/eye.2009.323","volume":"24","author":"TH Lim","year":"2010","unstructured":"Lim TH, Laude A, Tan CS (2010) Polypoidal choroidal vasculopathy: an angiographic discussion. Eye (Lond) 24(3):483\u2013490. https:\/\/doi.org\/10.1038\/eye.2009.323","journal-title":"Eye (Lond)"},{"issue":"8","key":"1299_CR9","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1097\/IAE.0b013e31820d3f3f","volume":"31","author":"TY Lai","year":"2011","unstructured":"Lai TY, Lee GK, Luk FO, Lam DS (2011) Intravitreal ranibizumab with or without photodynamic therapy for the treatment of symptomatic polypoidal choroidal vasculopathy. Retina 31(8):1581\u20131588. https:\/\/doi.org\/10.1097\/IAE.0b013e31820d3f3f","journal-title":"Retina"},{"issue":"8","key":"1299_CR10","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","volume":"32","author":"A Koh","year":"2012","unstructured":"Koh A, Lee WK, Chen LJ, Chen SJ, Hashad Y, Kim H, Lai TY, Pilz S, Ruamviboonsuk P, Tokaji E, Weisberger A, Lim TH (2012) EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 32(8):1453\u20131464. https:\/\/doi.org\/10.1097\/IAE.0b013e31824f91e8","journal-title":"Retina"},{"issue":"11","key":"1299_CR11","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","volume":"135","author":"A Koh","year":"2017","unstructured":"Koh A, Lai TYY, Takahashi K, Wong TY, Chen LJ, Ruamviboonsuk P, Tan CS, Feller C, Margaron P, Lim TH, Lee WK, group EIs, (2017) Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial. JAMA Ophthalmol 135(11):1206\u20131213. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.4030","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"1299_CR12","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00417-017-3718-6","volume":"255","author":"M Morimoto","year":"2017","unstructured":"Morimoto M, Matsumoto H, Mimura K, Akiyama H (2017) Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 255(10):1891\u20131897. https:\/\/doi.org\/10.1007\/s00417-017-3718-6","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1299_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002384","author":"JH Cho","year":"2018","unstructured":"Cho JH, Park YJ, Cho SC, Ryoo NK, Cho KH, Park SJ, Park KH, Woo SJ (2018) Posttreatment polyp regression and risk of massive submacular hemorrhage in eyes with polypoidal choroidal vasculopathy. Retina. https:\/\/doi.org\/10.1097\/IAE.0000000000002384","journal-title":"Retina"},{"issue":"2","key":"1299_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s10384-007-0501-y","volume":"52","author":"WK Lee","year":"2008","unstructured":"Lee WK, Lee PY, Lee SK (2008) Photodynamic therapy for polypoidal choroidal vasculopathy: vaso-occlusive effect on the branching vascular network and origin of recurrence. Jpn J Ophthalmol 52(2):108\u2013115. https:\/\/doi.org\/10.1007\/s10384-007-0501-y","journal-title":"Jpn J Ophthalmol"},{"issue":"2","key":"1299_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ajo.2012.02.019","volume":"154","author":"WK Lee","year":"2012","unstructured":"Lee WK, Kim KS, Kim W, Lee SB, Jeon S (2012) Responses to photodynamic therapy in patients with polypoidal choroidal vasculopathy consisting of polyps resembling grape clusters. Am J Ophthalmol 154(2):355\u2013365. https:\/\/doi.org\/10.1016\/j.ajo.2012.02.019","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"1299_CR16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/IAE.0b013e31816577cb","volume":"28","author":"E Akaza","year":"2008","unstructured":"Akaza E, Mori R, Yuzawa M (2008) Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy. Retina 28(5):717\u2013722. https:\/\/doi.org\/10.1097\/IAE.0b013e31816577cb","journal-title":"Retina"},{"key":"1299_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12886-015-0061-8","volume":"15","author":"IY Wong","year":"2015","unstructured":"Wong IY, Shi X, Gangwani R, Zhao P, Iu LP, Li Q, Ng A, Li X (2015) 1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy. BMC Ophthalmol 15:66. https:\/\/doi.org\/10.1186\/s12886-015-0061-8","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"1299_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12886-018-0952-6","volume":"18","author":"Y Iesato","year":"2018","unstructured":"Iesato Y, Tanaka M, Murata M, Kitahara J, Hirano T, Kurenuma T, Yoshida N, Murata T (2018) Complete regression of branching vascular network in polypoidal choroidal vasculopathy by ranibizumab and photodynamic therapy, two case reports. BMC Ophthalmol 18(1):284. https:\/\/doi.org\/10.1186\/s12886-018-0952-6","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"1299_CR19","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1364\/OE.20.004710","volume":"20","author":"Y Jia","year":"2012","unstructured":"Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, Kraus MF, Subhash H, Fujimoto JG, Hornegger J, Huang D (2012) Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express 20(4):4710\u20134725. https:\/\/doi.org\/10.1364\/OE.20.004710","journal-title":"Opt Express"},{"issue":"6","key":"1299_CR20","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.ophtha.2015.01.029","volume":"122","author":"TE de Carlo","year":"2015","unstructured":"de Carlo TE, Bonini Filho MA, Chin AT, Adhi M, Ferrara D, Baumal CR, Witkin AJ, Reichel E, Duker JS, Waheed NK (2015) Spectral-domain optical coherence tomography angiography of choroidal neovascularization. Ophthalmology 122(6):1228\u20131238. https:\/\/doi.org\/10.1016\/j.ophtha.2015.01.029","journal-title":"Ophthalmology"},{"key":"1299_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002234","author":"E Peiretti","year":"2018","unstructured":"Peiretti E, Iovino C, Sacconi R, Caminiti G, Querques G (2018) Optical coherence tomography angiography characteristics of polypoidal choroidal vasculopathy secondary to chronic central serous chorioretinopathy. Retina. https:\/\/doi.org\/10.1097\/IAE.0000000000002234","journal-title":"Retina"},{"issue":"9","key":"1299_CR22","doi-asserted-by":"publisher","first-page":"OCT526","DOI":"10.1167\/iovs.15-18955","volume":"57","author":"M Wang","year":"2016","unstructured":"Wang M, Zhou Y, Gao SS, Liu W, Huang Y, Huang D, Jia Y (2016) Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography. Invest Ophthalmol Vis Sci 57(9):OCT526\u2013OCT532. https:\/\/doi.org\/10.1167\/iovs.15-18955","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1299_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002139","author":"TE de Carlo","year":"2018","unstructured":"de Carlo TE, Kokame GT, Kaneko KN, Lian R, Lai JC, Wee R (2018) Sensitivity and specificity of detecting polypoidal choroidal vasculopathy with en face optical coherence tomography and optical coherence tomography angiography. Retina. https:\/\/doi.org\/10.1097\/IAE.0000000000002139","journal-title":"Retina"},{"issue":"11","key":"1299_CR24","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1136\/bjophthalmol-2015-307892","volume":"100","author":"M Srour","year":"2016","unstructured":"Srour M, Querques G, Semoun O, El Ameen A, Miere A, Sikorav A, Zambrowski O, Souied EH (2016) Optical coherence tomography angiography characteristics of polypoidal choroidal vasculopathy. Br J Ophthalmol 100(11):1489\u20131493. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307892","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"1299_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/lsm.22801","volume":"50","author":"Y Chen","year":"2018","unstructured":"Chen Y, Yang Z, Xia F, Ning H, Hua R (2018) The blood flow characteristics of polypoidal choroidal vasculopathy and the choroidal remodelling process after photodynamic therapy. Lasers Surg Med 50(5):427\u2013432. https:\/\/doi.org\/10.1002\/lsm.22801","journal-title":"Lasers Surg Med"},{"issue":"11","key":"1299_CR26","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1097\/IAE.0000000000000777","volume":"35","author":"M Inoue","year":"2015","unstructured":"Inoue M, Balaratnasingam C, Freund KB (2015) Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization. Retina 35(11):2265\u20132274. https:\/\/doi.org\/10.1097\/IAE.0000000000000777","journal-title":"Retina"},{"key":"1299_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2018.10.007","author":"E Eris","year":"2018","unstructured":"Eris E, Vural E (2018) Early retinal and choroidal effect of photodynamic treatment in patients with polypoidal choroidal vasculopathy with or without anti-vascular endothelial growth factor: an optical coherence tomography angiography study. Photodiagnosis Photodyn Ther. https:\/\/doi.org\/10.1016\/j.pdpdt.2018.10.007","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"11","key":"1299_CR28","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1097\/IAE.0000000000001047","volume":"36","author":"K Azuma","year":"2016","unstructured":"Azuma K, Obata R, Nomura Y, Tan X, Takahashi H, Yanagi Y (2016) Angiographic findings of ranibizumab-resistant polypoidal choroidal vasculopathy after switching to a treat-and-extend regimen with intravitreal aflibercept. Retina 36(11):2158\u20132165. https:\/\/doi.org\/10.1097\/IAE.0000000000001047","journal-title":"Retina"},{"issue":"8","key":"1299_CR29","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/bjo.2009.173120","volume":"94","author":"P Ruamviboonsuk","year":"2010","unstructured":"Ruamviboonsuk P, Tadarati M, Vanichvaranont S, Hanutsaha P, Pokawattana N (2010) Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary study. Br J Ophthalmol 94(8):1045\u20131051. https:\/\/doi.org\/10.1136\/bjo.2009.173120","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"1299_CR30","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1097\/IAE.0000000000000526","volume":"35","author":"F Gomi","year":"2015","unstructured":"Gomi F, Oshima Y, Mori R, Kano M, Saito M, Yamashita A, Iwata E, Maruko R, Fujisan Study G (2015) Initial versus delayed photodynamic therapy in combination with ranibizumab for treatment of polypoidal choroidal vasculopathy: The Fujisan Study. Retina 35(8):1569\u20131576","journal-title":"Retina"},{"issue":"6","key":"1299_CR31","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1167\/iovs.16-19204","volume":"57","author":"SJ Park","year":"2016","unstructured":"Park SJ, Choi Y, Na YM, Hong HK, Park JY, Park KH, Chung JY, Woo SJ (2016) Intraocular pharmacokinetics of intravitreal aflibercept (Eylea) in a rabbit model. Invest Ophthalmol Vis Sci 57(6):2612\u20132617. https:\/\/doi.org\/10.1167\/iovs.16-19204","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"1299_CR32","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1136\/bjo.2007.134874","volume":"92","author":"MW Stewart","year":"2008","unstructured":"Stewart MW, Rosenfeld PJ (2008) Predicted biological activity of intravitreal VEGF Trap. Br J Ophthalmol 92(5):667\u2013668. https:\/\/doi.org\/10.1136\/bjo.2007.134874","journal-title":"Br J Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-020-01299-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-020-01299-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-020-01299-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:22:13Z","timestamp":1612398133000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-020-01299-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,5]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1299"],"URL":"https:\/\/doi.org\/10.1007\/s10792-020-01299-3","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"type":"print","value":"0165-5701"},{"type":"electronic","value":"1573-2630"}],"subject":[],"published":{"date-parts":[[2020,2,5]]},"assertion":[{"value":"8 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}